Wound Closure Market Size, Share, Forecast, & Trends Analysis by Product (Suture, Needle, Tissue Adhesive, Sealant [Fibrin, Synthetic], Skin Stapler, Dressing [Foam, Film, Hydrogel]) Wound (Surgical, Trauma, Burn, DFU) End User

Description

List of Tables

Wound Closure Market Size, Share, Forecast, & Trends Analysis by Product (Suture, Needle, Tissue Adhesive, Sealant [Fibrin, Synthetic], Skin Stapler, Dressing [Foam, Film, Hydrogel]) Wound (Surgical, Trauma, Burn, DFU) End User-Global Forecast to 2031

The wound closure market is projected to reach $28.12 billion by 2031 at a CAGR of 6.8% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to the increasing number of surgeries, growth in chronic wound cases among the geriatric population, the growing incidence of traumatic injuries, increasing awareness about wound care, and the rising focus on infection prevention. However, the increasing number of minimally invasive surgeries and infections caused by wound closure devices restrain the growth of this market.

Furthermore, the technological advancements in wound closure products and the demand for wound closure in aesthetic procedures are expected to generate growth opportunities for the players operating in this market. However, antibiotic-resistant wound infections and product recalls are major challenges impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the wound closure market are 3M Company (U.S.), Medtronic plc (Ireland), Cardinal Health, Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), B. Braun Melsungen AG (Germany), Essity AB (Sweden), Medline Industries, LP (U.S.), Stryker Corporation (U.S.), Smith & Nephew plc (U.K.), Integra LifeSciences Corporation (U.S.), Organogenesis Inc. (U.S.), Coloplast A/S (Denmark), Convatec Group plc (U.K.), and Corza Medical (U.S.).

Among all the products studied in this report, the wound dressings segment is projected to register the highest CAGR of over 6.2% during the forecast period of 2024-2031. The growth of this segment is driven by the advancements in wound dressings, such as film dressings and foam dressings, which offer benefits such as reduced risk of wound breakdown, lower risk of infection, and faster healing. Furthermore, market players are focused on introducing innovative offerings to cater to the growing demand for wound dressings.

Among all the wound types studied in this report, in 2024, the acute wounds segment is expected to account for the larger share of the wound closure market. The large market share of this segment can be attributed to the increasing number of traumatic injuries such as falls, raid accidents, and burns and the increasing number of surgeries performed worldwide.

Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the wound closure market. The large market share of this segment can be attributed to the growing number of patient visits to hospitals & clinics for wound care & management and surgical procedures, the presence of highly skilled healthcare professionals, ease in accessibility, increasing healthcare expenditures, improving hospital infrastructure in emerging economies, and the increasing adoption of advanced wound closure products among hospitals & clinics.

An in-depth analysis of the geographical scenario of the wound closure market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 38.3% of the wound closure market. In the region in 2024, the U.S. is expected to account for the largest share of the wound closure market in North America. The large share of this regional market is attributed to the presence of major wound closure companies such as 3M Company (U.S.), Johnson & Johnson Services, Inc. (U.S.), and Cardinal Health, Inc. (U.S.), the high adoption of advanced wound closure devices in hospitals & clinics, the increasing cases of chronic wounds such as diabetic foot ulcers, and favorable reimbursement policies in the region.

Scope of the Report:

Wound Closure Market Assessment-by Product

Sutures
- Absorbable Sutures
- Non-absorbable Sutures
- Suturing Devices
Needles
Tissue Adhesives
Topical/Local Hemostats
Sealants
- Fibrin Sealants
- Synthetic Sealants
Skin Staplers
- Powered
- Manual
- Stapler Accessories
Wound Dressings
- Hydrocolloid Dressings
- Foam Dressings
- Alginate Dressings
- Film Dressings
- Collagen Dressings
- Hydrogel Dressings
- Other Wound Dressings
Wound Closure Devices
Other Products & Accessories

Note: Other Wound Dressings include composite dressings, transparent dressings, and hydrofiber dressings.

Note: Wound Closure Devices include zips, strips, and bandages.

Note: Other Products & Accessories include meshes, pledgets, needle holders, pacing leads, bolsters, and hydrogels.

Wound Closure Market Assessment-by Wound Type

Acute Wounds
- Surgical Wounds
- Traumatic Wounds
- Burns
Chronic Wounds
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Other Chronic Wounds

Note: Other chronic wounds include arterial ulcers and acute & sub-acute ulcers.

Wound Closure Market Assessment-by End User

Hospitals & Clinics
Ambulatory Surgical Centers
Home Care Settings
Other End Users

Note: Other End Users include academic & research institutes, long-term care centers, and defense.

Wound Closure Market Assessment-by Geography

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K
- Italy
- Spain
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa

Product Code: MRHC - 1041153

1. Introduction

1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Process of Data Collection & Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

4.1. Overview
4.2. Drivers
- 4.2.1. Increasing Number of Surgeries Performed Globally
- 4.2.2. Increasing Geriatric Population with Chronic Wounds
- 4.2.3. Growing Traumatic Injuries
- 4.2.4. Increasing Awareness Regarding Wound Care
- 4.2.5. Rising Focus on Preventing Wound Infection
4.3. Restraints
- 4.3.1. Increasing Number of Minimally Invasive Surgeries
- 4.3.2. Infections Caused Due to Wound Closure Devices
4.4. Opportunities
- 4.4.1. Technological Advancements in Wound Closure Products
- 4.4.2. Demand for Wound Closure in Aesthetic Procedures
4.5. Challenges
- 4.5.1. Antibiotic-resistant Wound Infections
- 4.5.2. Product Recalls
4.6. Trends
- 4.6.1. Growing Demand for Bioactive Wound Care Solutions
4.7. Factor Analysis
4.8. Regulatory Analysis
4.9. Pricing Analysis
4.10. Case Studies
4.11. Porter's Five Forces Analysis

5. Wound Closure Market Assessment-by Product

5.1. Overview
5.2. Sutures
- 5.2.1. Absorbable Sutures
- 5.2.2. Non-absorbable Sutures
- 5.2.3. Suturing Devices
5.3. Needles
5.4. Tissue Adhesives
5.5. Topical/Local Hemostats
5.6. Sealants
- 5.6.1. Fibrin Sealants
- 5.6.2. Synthetic Sealants
5.7. Skin Staplers
- 5.7.1. Powered
- 5.7.2. Manual
- 5.7.3. Stapler Accessories
5.8. Wound Dressings
- 5.8.1. Hydrocolloid Dressings
- 5.8.2. Foam Dressings
- 5.8.3. Alginate Dressings
- 5.8.4. Film Dressings
- 5.8.5. Collagen Dressings
- 5.8.6. Hydrogel Dressings
- 5.8.7. Other Wound Dressings
5.9. Wound Closure Devices
5.10. Other Products & Accessories

6. Wound Closure Market Assessment-by Wound Type

6.1. Overview
6.2. Acute Wounds
- 6.2.1. Surgical Wounds
- 6.2.2. Traumatic Wounds
- 6.2.3. Burns
6.3. Chronic Wounds
- 6.3.1. Diabetic Foot Ulcers
- 6.3.2. Venous Leg Ulcers
- 6.3.3. Pressure Ulcers
- 6.3.4. Other Chronic Wounds

7. Wound Closure Market Assessment-by End User

7.1. Overview
7.2. Hospitals & Clinics
7.3. Ambulatory Surgical Centers
7.4. Home Care Settings
7.5. Other End Users

8. Wound Closure Market Assessment-by Geography

8.1. Overview
8.2. North America
- 8.2.1. U.S.
- 8.2.2. Canada
8.3. Europe
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Switzerland
- 8.3.7. Belgium
- 8.3.8. Rest of Europe
8.4. Asia-Pacific
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. South Korea
- 8.4.6. Rest of Asia-Pacific
8.5. Latin America
- 8.5.1. Brazil
- 8.5.2. Mexico
- 8.5.3. Rest of Latin America
8.6. Middle East & Africa

9. Competition Analysis

9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
- 9.4.1. Industry Leaders
- 9.4.2. Market Differentiators
- 9.4.3. Vanguards
- 9.4.4. Emerging Companies
9.5. Market Share Analysis/Market Rankings of Key Players (2023)

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

10.1. 3M Company
10.2. Medtronic plc
10.3. Cardinal Health, Inc.
10.4. Johnson & Johnson Services, Inc.
10.5. B. Braun Melsungen AG
10.6. Essity AB
10.7. Medline Industries, LP
10.8. Stryker Corporation
10.9. Smith & Nephew plc
10.10. Integra LifeSciences Corporation
10.11. Organogenesis Inc.
10.12. Coloplast A/S
10.13. Convatec Group plc
10.14. Corza Medical

(Note: SWOT analyses of the top 5 companies will be provided.)

11. Appendix

11.1. Available Customization
11.2. Related Reports